Trials / Sponsors / Shanghai CP Guojian Pharmaceutical Co., Ltd.
Shanghai CP Guojian Pharmaceutical Co., Ltd.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study for HER2-Overexpressed MBC Patients Treated by Cipterbin® Plus vinorelbinE Progress-free Survival, Overall Response Rate, Adverse Events | — | 2009-05-01 |
| Completed | Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma Diffuse Large B Cell Lymphoma | Phase 3 | 2006-09-01 |
| Completed | Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Metastatic Breast Cancer | Phase 2 | 2005-07-01 |